UBS raises price target for Nanobiotix

UBS has raised its price target for French biotechnology group Nanobiotix.

Published 11sem1 source

≈ 16sSpeed

The fact

This upward revision signals increased analyst confidence in the cancer research company's prospects.

The move may strengthen investor interest in the listed stock.

Click the link to read an article on the topic:

Explore this topic

Auto-synthesis from 1 media source · identified on May 3, 2026